Thus, siPOLA1-mediated sensitization to ATR and CHK1 inhibitors is not a cell line-specific phenomenon of DLD-1 cells but can be generalized to a panel of cell lines of different tumor entities. The gene discussed is ATR; the disease is neoplasm.